← The Wire
ABCLNasdaq
AbCellera Biologics Inc.
Pharmaceutical Preparations · A1 · CIK 1703057
AbCellera discovers antibodies for drug development partners, generating revenue from upfront and downstream payments
red 8-K · 90d
$1.60B
Market cap
$8.12
Last close
+10.0%
1D
+41.5%
5D
16.2M
Volume
Price · last 39 sessions+76.9%
May 4L $4.05 · H $8.12Jun 29
105
Total filings
Jun 17, 2026
Last filing
12/31
Fiscal year end
8-KCompany UpdateJun 17, 20268-KShareholder VoteJun 12, 20268-KExecutive ChangeJun 5, 202610-Q10-QMay 11, 20268-KResults of Operations · Reg FD DisclosureMay 11, 2026DEFA14ADEFA14AApr 29, 2026DEF 14ADEF 14AApr 29, 202610-K10-KFeb 24, 20268-KResults of Operations · Reg FD DisclosureFeb 24, 20268-KReg FD DisclosureJan 14, 20268-KReg FD DisclosureDec 18, 20258-KAuditor ChangeNov 28, 20258-KExecutive ChangeNov 12, 202510-Q10-QNov 6, 20258-KResults of Operations · Reg FD DisclosureNov 6, 20258-KCompany UpdateSep 10, 202510-Q10-QAug 7, 20258-KResults of Operations · Reg FD DisclosureAug 7, 20258-KShareholder VoteJun 13, 20258-KCompany UpdateMay 30, 20258-KCompany UpdateMay 14, 20258-KCompany UpdateMay 13, 202510-Q10-QMay 8, 20258-KResults of Operations · Reg FD DisclosureMay 8, 2025DEFA14ADEFA14AApr 29, 2025DEF 14ADEF 14AApr 29, 202510-K10-KFeb 27, 20258-KResults of Operations · Reg FD DisclosureFeb 27, 20258-KCompany UpdateFeb 18, 202510-Q10-QNov 4, 20248-KResults of Operations · Reg FD DisclosureNov 4, 202410-Q10-QAug 6, 20248-KResults of Operations · Reg FD DisclosureAug 6, 20248-KShareholder VoteJun 13, 202410-Q10-QMay 7, 20248-KResults of Operations · Reg FD DisclosureMay 7, 2024DEFA14ADEFA14AApr 29, 2024DEF 14ADEF 14AApr 29, 20248-KExecutive ChangeFeb 23, 202410-K10-KFeb 20, 20248-KResults of Operations · Reg FD DisclosureFeb 20, 2024SC 13GSC 13GFeb 14, 20248-KCompany UpdateNov 28, 202310-Q10-QNov 2, 20238-KResults of Operations · Reg FD DisclosureNov 2, 20238-KCompany UpdateOct 13, 202310-Q10-QAug 3, 20238-KResults of Operations · Reg FD DisclosureAug 3, 20238-KShareholder VoteJun 20, 20238-KMaterial Agreement · New Debt / ObligationMay 24, 202310-Q10-QMay 4, 20238-KResults of Operations · Reg FD DisclosureMay 4, 2023DEFA14ADEFA14AApr 28, 2023DEF 14ADEF 14AApr 28, 20238-KReg FD DisclosureMar 13, 202310-K10-KFeb 21, 20238-KResults of Operations · Reg FD DisclosureFeb 21, 2023SC 13GSC 13GJan 18, 202310-Q10-QNov 8, 20228-KResults of Operations · Reg FD DisclosureNov 8, 202210-Q10-QAug 9, 20228-KResults of Operations · Reg FD DisclosureAug 9, 202210-K/A10-K/AJul 22, 20228-KExecutive ChangeJul 19, 20228-KExecutive ChangeJul 6, 20228-KReg FD DisclosureJun 30, 20228-KShareholder VoteJun 21, 202210-Q10-QMay 10, 20228-KResults of Operations · Reg FD DisclosureMay 10, 2022DEFA14ADEFA14AApr 28, 2022DEF 14ADEF 14AApr 28, 202210-K10-KFeb 25, 20228-KResults of Operations · Reg FD DisclosureFeb 24, 20228-KReg FD DisclosureFeb 15, 2022SC 13GSEC SCHEDULE 13GFeb 11, 20228-KExecutive ChangeDec 7, 20218-KReg FD DisclosureDec 3, 202110-Q10-QNov 10, 20218-KResults of Operations · Reg FD DisclosureNov 9, 20218-KReg FD DisclosureNov 4, 2021
Insider Activity
◆ Cluster Buy · 2 insidersIn the 90 days to Feb 27, 2026: 2 insiders bought $857K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 27, 2026 | Booth AndrewChief Financial Officer | Buy | 42,600 | $3.42 | $146K |
| Feb 27, 2026 | Thermopylae Holdings Ltd.TenPercentOwner | Buy | 38,000 | $3.44 | $131K |
| Feb 26, 2026 | Thermopylae Holdings Ltd.TenPercentOwner | Buy | 177,457 | $3.27 | $580K |
| Nov 26, 2025 | Montalbano John S.Director | Buy | 50,000 | $3.57 | $179K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance